1. Identification of conserved skeletal enhancers associated with craniosynostosis risk genes
- Author
-
He, Xuan Anita, Berenson, Anna, Bernard, Michelle, Weber, Chris, Cook, Laura E, Visel, Axel, Bass, Juan I Fuxman, and Fisher, Shannon
- Subjects
Biological Sciences ,Genetics ,Human Genome ,Congenital Structural Anomalies ,Rare Diseases ,Dental/Oral and Craniofacial Disease ,Pediatric ,Aetiology ,2.1 Biological and endogenous factors ,Musculoskeletal ,Craniosynostoses ,Animals ,Zebrafish ,Enhancer Elements ,Genetic ,Humans ,Mice ,Genome-Wide Association Study ,Bone Morphogenetic Protein 2 ,Genetic Predisposition to Disease ,Conserved Sequence ,Zebrafish Proteins ,Animals ,Genetically Modified ,Mutation ,conserved regulatory elements ,zebrafish transgenesis ,craniosynostosis ,enhanced yeast one-hybrid assay ,BMP signaling ,Medical and Health Sciences ,Genetics & Heredity - Abstract
Craniosynostosis, defined by premature fusion of one or multiple cranial sutures, is a common congenital defect affecting more than 1/2000 infants and results in restricted brain expansion. Single gene mutations account for 15%-20% of cases, largely as part of a syndrome, but the majority are nonsyndromic with complex underlying genetics. We hypothesized that the two noncoding genomic regions identified by a GWAS for craniosynostosis contain distal regulatory elements for the risk genes BMPER and BMP2. To identify such regulatory elements, we surveyed conserved noncoding sequences from both risk loci for enhancer activity in transgenic Danio rerio. We identified enhancers from both regions that direct expression to skeletal tissues, consistent with the endogenous expression of bmper and bmp2. For each locus, we also found a skeletal enhancer that also contains a sequence variant associated with craniosynostosis risk. We examined the activity of each enhancer during craniofacial development and found that the BMPER-associated enhancer is active in the restricted region of cartilage closely associated with frontal bone initiation. The same enhancer is active in mouse skeletal tissues, demonstrating evolutionarily conserved activity. Using enhanced yeast one-hybrid assays, we identified transcription factors that bind each enhancer and observed differential binding between alleles, implicating multiple signaling pathways. Our findings help unveil the genetic mechanism of the two craniosynostosis risk loci. More broadly, our combined in vivo approach is applicable to many complex genetic diseases to build a link between association studies and specific genetic mechanisms.
- Published
- 2024